vs
OHIO VALLEY BANC CORP(OVBC)与礼来(RNA)财务数据对比。点击上方公司名可切换其他公司
OHIO VALLEY BANC CORP的季度营收约是礼来的1.3倍($16.2M vs $12.5M),OHIO VALLEY BANC CORP净利率更高(24.4% vs -1398.3%,领先1422.7%),礼来同比增速更快(434.0% vs -4.6%),OHIO VALLEY BANC CORP自由现金流更多($17.0M vs $-156.9M),过去两年礼来的营收复合增速更高(138.5% vs 4.3%)
俄亥俄谷银行公司旗下的亚利桑那 Valley 国民银行总部位于亚利桑那州凤凰城,成立于1900年,1992年被第一银行收购。该银行是20世纪亚利桑那州顶尖的金融机构之一,在被收购时是该州最后一家大型独立银行。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业,在18个国家设有办事处,产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立,品牌名即取自创始人姓名。
OVBC vs RNA — 直观对比
营收规模更大
OVBC
是对方的1.3倍
$12.5M
营收增速更快
RNA
高出438.7%
-4.6%
净利率更高
OVBC
高出1422.7%
-1398.3%
自由现金流更多
OVBC
多$173.9M
$-156.9M
两年增速更快
RNA
近两年复合增速
4.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $16.2M | $12.5M |
| 净利润 | $4.0M | $-174.4M |
| 毛利率 | — | — |
| 营业利润率 | 30.7% | -1513.5% |
| 净利率 | 24.4% | -1398.3% |
| 营收同比 | -4.6% | 434.0% |
| 净利润同比 | 57.3% | -117.0% |
| 每股收益(稀释后) | — | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
OVBC
RNA
| Q4 25 | $16.2M | — | ||
| Q3 25 | $16.3M | $12.5M | ||
| Q2 25 | $17.4M | $3.8M | ||
| Q1 25 | $16.8M | $1.6M | ||
| Q4 24 | $17.0M | $3.0M | ||
| Q3 24 | $15.4M | $2.3M | ||
| Q2 24 | $14.7M | $2.0M | ||
| Q1 24 | $14.9M | $3.5M |
净利润
OVBC
RNA
| Q4 25 | $4.0M | — | ||
| Q3 25 | $3.0M | $-174.4M | ||
| Q2 25 | $4.2M | $-157.3M | ||
| Q1 25 | $4.4M | $-115.8M | ||
| Q4 24 | $2.5M | $-102.3M | ||
| Q3 24 | $2.7M | $-80.4M | ||
| Q2 24 | $3.0M | $-70.8M | ||
| Q1 24 | $2.8M | $-68.9M |
营业利润率
OVBC
RNA
| Q4 25 | 30.7% | — | ||
| Q3 25 | 22.9% | -1513.5% | ||
| Q2 25 | 29.8% | -4448.7% | ||
| Q1 25 | 33.1% | -8360.9% | ||
| Q4 24 | 18.1% | -4069.6% | ||
| Q3 24 | 21.3% | -4200.9% | ||
| Q2 24 | 24.7% | -4040.4% | ||
| Q1 24 | 22.8% | -2178.6% |
净利率
OVBC
RNA
| Q4 25 | 24.4% | — | ||
| Q3 25 | 18.5% | -1398.3% | ||
| Q2 25 | 24.2% | -4089.3% | ||
| Q1 25 | 26.2% | -7360.0% | ||
| Q4 24 | 14.8% | -3439.5% | ||
| Q3 24 | 17.6% | -3441.7% | ||
| Q2 24 | 20.3% | -3461.8% | ||
| Q1 24 | 18.8% | -1943.4% |
每股收益(稀释后)
OVBC
RNA
| Q4 25 | — | — | ||
| Q3 25 | — | $-1.27 | ||
| Q2 25 | — | $-1.21 | ||
| Q1 25 | — | $-0.90 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.65 | ||
| Q2 24 | — | $-0.65 | ||
| Q1 24 | — | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $45.9M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $170.3M | $1.9B |
| 总资产 | $1.6B | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
OVBC
RNA
| Q4 25 | $45.9M | — | ||
| Q3 25 | $89.3M | $350.2M | ||
| Q2 25 | $54.6M | $243.9M | ||
| Q1 25 | $120.6M | $254.2M | ||
| Q4 24 | $83.1M | $219.9M | ||
| Q3 24 | $82.2M | $370.2M | ||
| Q2 24 | $107.7M | $575.8M | ||
| Q1 24 | $129.1M | $471.4M |
股东权益
OVBC
RNA
| Q4 25 | $170.3M | — | ||
| Q3 25 | $164.4M | $1.9B | ||
| Q2 25 | $160.8M | $1.2B | ||
| Q1 25 | $155.7M | $1.3B | ||
| Q4 24 | $150.3M | $1.4B | ||
| Q3 24 | $152.2M | $1.5B | ||
| Q2 24 | $145.8M | $1.2B | ||
| Q1 24 | $145.8M | $830.9M |
总资产
OVBC
RNA
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | $2.1B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.5B | ||
| Q4 24 | $1.5B | $1.6B | ||
| Q3 24 | $1.5B | $1.6B | ||
| Q2 24 | $1.4B | $1.3B | ||
| Q1 24 | $1.4B | $951.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $18.1M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $17.0M | $-156.9M |
| 自由现金流率自由现金流/营收 | 105.2% | -1257.6% |
| 资本支出强度资本支出/营收 | 6.4% | 5.7% |
| 现金转化率经营现金流/净利润 | 4.57× | — |
| 过去12个月自由现金流最近4个季度 | $26.5M | $-592.3M |
8季度趋势,按日历期对齐
经营现金流
OVBC
RNA
| Q4 25 | $18.1M | — | ||
| Q3 25 | $5.3M | $-156.2M | ||
| Q2 25 | $4.5M | $-199.7M | ||
| Q1 25 | $496.0K | $-124.8M | ||
| Q4 24 | $13.1M | $-99.9M | ||
| Q3 24 | $5.6M | $-65.6M | ||
| Q2 24 | $4.2M | $-65.0M | ||
| Q1 24 | $928.0K | $-70.4M |
自由现金流
OVBC
RNA
| Q4 25 | $17.0M | — | ||
| Q3 25 | $5.0M | $-156.9M | ||
| Q2 25 | $4.4M | $-203.0M | ||
| Q1 25 | $138.0K | $-128.6M | ||
| Q4 24 | $11.7M | $-103.8M | ||
| Q3 24 | $5.4M | $-67.3M | ||
| Q2 24 | $3.9M | $-65.5M | ||
| Q1 24 | $234.0K | $-71.3M |
自由现金流率
OVBC
RNA
| Q4 25 | 105.2% | — | ||
| Q3 25 | 30.4% | -1257.6% | ||
| Q2 25 | 25.1% | -5277.1% | ||
| Q1 25 | 0.8% | -8174.3% | ||
| Q4 24 | 68.7% | -3491.0% | ||
| Q3 24 | 35.1% | -2881.8% | ||
| Q2 24 | 26.3% | -3204.6% | ||
| Q1 24 | 1.6% | -2012.3% |
资本支出强度
OVBC
RNA
| Q4 25 | 6.4% | — | ||
| Q3 25 | 2.1% | 5.7% | ||
| Q2 25 | 0.6% | 86.9% | ||
| Q1 25 | 2.1% | 238.6% | ||
| Q4 24 | 8.4% | 131.7% | ||
| Q3 24 | 1.2% | 72.9% | ||
| Q2 24 | 2.2% | 26.0% | ||
| Q1 24 | 4.7% | 25.8% |
现金转化率
OVBC
RNA
| Q4 25 | 4.57× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | 5.21× | — | ||
| Q3 24 | 2.06× | — | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 0.33× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图